Vorsitz/Chair: Denise Hilfiker-Kleiner (Hannover), Andreas Zietzer (Bonn)
Agenda
11:15
(V1106)
MiR-92b-3p influences apoptosis in vascular smooth muscle cells by targeting BCL2L11, offering potential new therapeutic strategies for vascular remodeling
K. Kalies (Halle (Saale))
Zum Abstract
11:22
Diskussion
11:26
(V1107)
Cigarette smoking upregulates vascular expression of the novel atherosclerosis risk factor ADAMTS-7 via CCL17-CCR4 signaling
C. Abrahamian (München)
Zum Abstract
11:33
Diskussion
11:37
(V1108)
Protein Profiling of Smooth Muscle Cell Responses to Intramural Puromycin Administration Upon Balloon Angioplasty In Rabbit Model
P. Böttger (Gießen)
Zum Abstract
11:44
Diskussion
11:48
(V1109)
MicroRNA-31-5p is upregulated in murine neointimal tissue and significantly impacts smooth muscle cell-mediated vascular remodeling through its interaction with STK40
S. Gürlach (Halle (Saale))
Zum Abstract
11:55
Diskussion
11:59
(V1110)
Deletion of protein tyrosine phosphatase 1B in vascular fibroblasts promotes proliferation and pathological vascular remodeling by enhancing PDGFRB signaling
I. Ghasemi (Mainz)
Zum Abstract
12:06
Diskussion
12:10
(V1111)
PI3Kα und PI3Kδ schützen durch Steuerung von Funktionen glatter Gefäßmuskelzellen und regulatorischer T-Zellen vor Arteriosklerose-Progression und Plaque-Instabilität
M. Zierden (Köln)
Zum Abstract
12:17
Diskussion
12:21
(V1112)
miR-331-3p as a modulator of vascular smooth muscle cell function in atherosclerosis
S. Laube (Halle (Saale))
Zum Abstract
12:28
Diskussion
12:32
(V1113)
Deletion of arginase-1 in murine erythrocytes promotes smooth muscle lipid uptake, foam cell formation and atherosclerosis progression